Levosimendan Versus Dobutamine in Shock Patients - Tabular View

Tracking Information
First Received Date ^ICMJE	October 5, 2004
Last Updated Date	June 23, 2005
Start Date ^ICMJE	October 2004
Primary Completion Date
Current Primary Outcome Measures ^ICMJE (submitted: June 23, 2005)	Resolution of shock state
Original Primary Outcome Measures ^ICMJE	Same as current
Change History	Complete list of historical versions of study NCT00093301 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE (submitted: June 23, 2005)	Change in cardiac functions
Original Secondary Outcome Measures ^ICMJE	Same as current

Descriptive Information
Brief Title ^ICMJE	Levosimendan Versus Dobutamine in Shock Patients
Official Title ^ICMJE	Efficacy of Levosimendan in the Critically Ill Patients With Unstable Hemodynamics (the LICI Study) - A Double Blind Randomized Pilot Study
Brief Summary	The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).
Detailed Description
Study Phase	Phase II, Phase III
Study Type ^ICMJE	Interventional
Study Design ^ICMJE	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Condition ^ICMJE	Cardiogenic Shock Septic Shock
Intervention ^ICMJE	Drug: Levosimendan Drug: Dobutamine
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Recruiting
Enrollment ^ICMJE	40
Completion Date	April 2006
Primary Completion Date
Eligibility Criteria ^ICMJE	Inclusion Criteria: Reduced left ventricular systolic function Hypotension Anuria or oligouria Exclusion Criteria: Less than 18 years old Pregnant Uncorrected valvular stenosis Hypertrophic obstructive cardiomyopathy (HOCM) Third degree AV block
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE
Location Countries ^ICMJE	Australia

Administrative Information
NCT ID ^ICMJE	NCT00093301
Responsible Party
Study ID Numbers ^ICMJE	03/007
Study Sponsor ^ICMJE	Wentworth Area Health Services
Collaborators ^ICMJE	Abbott
Investigators ^ICMJE
Information Provided By	Wentworth Area Health Services
Verification Date	October 2004
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP